Companies › ZIVO
ZIVO BIOSCIENCE INC (ZIVO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001101026 · EDGAR filings · Updated 2026-04-24
ZIVO BIOSCIENCE INC (ZIVO) has reported institutional ownership of 0.1%, with 3 institutional managers holding positions valued at $33.5K per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-04-24 — Insider transaction reported (Form 4)
- 2026-04-01 — EFFECT filed
- 2026-03-31 — 15-12G filed
- 2026-03-31 — S-8 POS filed
- 2026-03-31 — POS AM filed
- 2026-03-30 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ZIVO BIOSCIENCE INC has 3 institutional holders and institutional ownership of 0.1%.
Insider activity
Insiders reported 16 transactions (15 buys, 1 sells) across 7 reporting insiders, with a net reported value of $1.52M.
Data flags from SEC filings
Related companies
VAXART INC (VXRT) · ITONIC HOLDINGS LTD (ITOC) · NewGenIvf Group Ltd (NIVF) · PRF TECHNOLOGIES LTD (PRFX) · AKANDA CORP (AKAN) · CUPRINA HLDGS (CAYMAN) LTD (CUPR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-04-24.